ImmunologybioRxivPreprint
Development of MHC Class I Blocking Peptides to Target Metabolic Dysfunction-Associated Steatohepatitis CD8+ T Cell Activation
Victoria R. Adams, Sudeep Sarma, Carol K. Hall, Arion J. Kennedy
The paper develops MHC class I blocking peptides to inhibit CD8+ T cell activation in MASH, reducing inflammation and fibrosis.
DOI 10.1101/2024.03.12.584666